The FDA has granted 510(k) clearance to the iPRIME viscodelivery system, according to a press release from Glaukos.
iPRIME is a single-use, sterile, minimally invasive device used to deliver viscoelastic fluid during ophthalmic surgery.
“We are thrilled to announce this clearance as we believe iPRIME will be another important tool that supports the needs of physicians and patients,” Thomas Burns, Glaukos president and CEO, said in the release. “This technology further expands Glaukos’ broad portfolio of innovative ophthalmic solutions and is consistent with our